Business News

The Saints Are On The Move: Rahul Deshpande's Abhangawari Takes Maharashtra's Soul Across India

Advances in cancer treatment are improving survival and quality of life through precision medicine, innovative therapies, Proton Beam Therapy, and the da Vinci Xi robotic surgical system

A New Lease of Life: Stories of Hope, Survivorship and Second Chances with Apollo Hospitals

Jun 08, 2026

Trex Energy Launches REX BESS 125kW/261kWh with Liquid-Cooling (C&I) to Support Smart Industrial Energy Infrastructure

Jun 08, 2026

Vikas Sharma VIIN Ventures, Gautam C. Lodha Strata, Anubhav Tripathi, Gaurav Kumar & Adithya Murali Yubi Markets, Sathishkumar and Balamurugan DAC Developers, with Srijan Sharma

DAC Developers Opens Satellite Office on OMR and launches Cambridge -- Chennai's First English-Themed Residence

Jun 08, 2026

PR Newswire Signs Affiliate Membership with PRCAI to Strengthen India's Communications Ecosystem

Jun 08, 2026

Softcell Technologies Global Private Limited Achieves Zscaler Delivery Services Authorization

Jun 08, 2026

Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data

Jun 08, 2026

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

Jun 08, 2026

More News

Shilpa Medicare and Gate2brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy

Jun 08, 2026

Barcelona [Spain] / Raichur (Karnataka) [India], June 8: Shilpa Biocare Pvt Ltd, a subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 -- Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28.

OpenAI eyes big ChatGPT redesign

Jun 08, 2026

Doha [Qatar], June 8: OpenAI is planning its biggest ChatGPT overhaul yet, aiming to turn it into a "superapp" with coding tools and AI agents to boost revenue ahead of a potential stock market listing, the Financial Times reported on Sunday. The changes are part of a broader reorganization at OpenAI, as it shifts resources to target lucrative enterprise clients and intensify competition with rival Anthropic, the report said, citing more than a dozen current and formeremployees.

Global trade under strain as sea routes face rising disruption risks

Jun 08, 2026

Doha [Qatar], June 8: International organizations, specialized studies, and economic reports traditionally classify countries as either coastal states with direct access to maritime trade routes or landlocked nations lacking seaports and maritime outlets.